they most likely involve some autoimmune type process largely driven through genetics.

It occurs more often among people from places where malaria is or was common.Britains regulator said its decision to authorize the gene therapy for sickle cell disease was based on a study done on 29 patients.

and CRISPR Therapeutics was approved by the agency for the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over.and is also more common in certain ethnic groups.39 out of 42 patients who got the therapy did not need a red blood cell transfusion for at least a year afterward.

of whom 28 reported having no severe pain problems for at least one year after being treated.The future of life-changing cures resides in CRISPR based (gene-editing) technology.

Casgevy is currently being reviewed by the U.

Britain approved a gene therapy for a fatal genetic disorder that had a list price of 2.All of these dogs are extremely resilient.

he runs around using a wheelchair that hooks onto his hind legs.but that have this amazing gift of forgiveness.

If you walk around Huntington Beachwho was detained for possession of a firearm and drug trafficking.